CDMO Landscape Seeing Changes as Consolidation Continues
The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.
RNA’s Expanding Horizons
As the RNA therapeutic market grows, contract manufacturing services for GMP-grade RNA are in demand and expected to continue on an upward trajectory.
Challenges When Outsourcing Viral Safety Services
Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
Ensuring Contract Manufacturing Facilities Are Up to Speed
The COVID-19 pandemic has triggered additional considerations to supplier oversight of contract manufacturing facilities.
Succeeding with Remote Audits
Preparation is key for remote vendor and contract partner audits.
Demystifying Complex Clinical Trial Kit Prep
Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.
CDMO Partnerships Boost Company Capabilities
Recent CDMO partnerships include COVID-19 collaborations, manufacturing partnerships, service agreements, and a strategic alliance expansion.
